期刊文献+

PKM2在肿瘤形成中的作用及其活性调节 被引量:2

The Function of PKM2 in Tumorigenesis and Its Activity Regulation
原文传递
导出
摘要 肿瘤细胞利用有氧糖酵解将葡萄糖转变为细胞代谢及增殖所需的物质,如核苷酸、氨基酸和脂质等,并产生ATP。丙酮酸激酶是糖酵解途径中的限速酶,催化磷酸烯醇式丙酮酸生成丙酮酸。其四种同工酶之一PKM2(pyruvate kinase M2),由四个亚基组成,有单体、二聚体及四聚体等多种存在形式。其中,PKM2四聚体活性最强,能促进葡萄糖通过氧化磷酸化彻底氧化分解生成ATP,而其二聚体则促进Warburg效应,即葡萄糖的有氧酵解。两者之间的平衡在肿瘤形成中起到了很重要的作用,同时也受到一系列因子的调控。该文就PKM2在肿瘤代谢中的作用及其活性调节作一介绍。 The tumor cells can transfer glucose to metabolites required for cell metabolism and proliferation through aerobic glycolysis, such as nucleotides, amino acids, lipids, as well as adenosine triphosphate(ATP). Pyruvate kinase, one of the rate-limiting enzymes in the glycolytic pathway, catalyzes the substrate phosphoenolpyruvicacid to be transformed into pyruvate. One of its four isozymes, pyruvate kinase M2(PKM2), is consisted of four subunits. It can exist in forms of monomer, dimer, trimer or tetramer. PKM2 tetramer is the most active form which motivates glucose to be totally oxidized, producing ATP through oxidative phosphorylation. Nevertheless PKM2 dimer prones to promote the glucose aerobic glycolysis, which is commonly observed in tumor cells named the Warburg effect. The balance between PKM2 dimer and tetramer, which is modulated by a series of regulating factors, plays an important role in tumorigenesis. In this review, we briefly introduce the function of PKM2 in tumorigenesis and its activity regulation.
出处 《中国细胞生物学学报》 CAS CSCD 2015年第4期582-587,共6页 Chinese Journal of Cell Biology
基金 上海交通大学医学院临床医学八年制RBL项目 上海市自然科学基金(批准号:13ZR1422900)资助的课题~~
关键词 PKM2 Warburg效应 肿瘤代谢 肿瘤形成 酶的活性调节 PKM2 Warburg effect tumor metabolism tumorigenesis regulation of enzyme activity
作者简介 通讯作者。Tel:021—63846590-778026,Fax:021-64661525,E-mail:ccairong@126.com
  • 相关文献

参考文献34

  • 1Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324(5930): 1029-33.
  • 2Gordan JD, Thompson CB, Simon MC. HIF and c-Myc: Sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007; 12(2): 108-13.
  • 3Keller KE, Tan IS, Lee YS. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 2012; 338(6110): 1069-72.
  • 4Wong N, Ojo D, Yan J, Tang D. PKM2 contributes to cancer metabolism. Cancer Lett 2015; 356(2 PtA): 184-91.
  • 5Chaneton B, Hillmann P, Zheng L, Martin AC, Maddocks OD, Chokkathukalam A, et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 2012; 491(7424): 458- 62.
  • 6Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452(7184): 230-3.
  • 7Brinck U, Eigenbrodt E, Oehmke M, Mazurek S, Fischer G. L-and M2-pyruvate kinase expression in renal cell carcinomas and their metastases. Virchows Arch 1994; 424(2): 177-85.
  • 8Schneider J, Neu K, Grimm H, Velcovsky HG, Weisse G, Eigenbrodt E. Tumor M2-pyruvate kinase in lung cancer patients: Immunohistochemical detection and disease monitoring. Anticancer Res 2002; 22(1A): 311-8.
  • 9Luftner D, Mesterharm J, Akrivakis C, Geppert R, Petrides PE, Wemeeke KD, et al. Tumor type M2 pyruvate kinase expression in advanced breast cancer. Anticancer Res 2000; 20(6D): 5077- 82.
  • 10Hardt PD, Toepler M, Ngoumou B, Rupp J, Kloer HU. Measurement of fecal pyruvate kinase type M2 (tumor M2-PK) concentrations in patients with gastric cancer, colorectal cancer, colorectal adenomas and controls. Antieancer Res 2003; 23(2A): 851-3.

二级参考文献39

  • 1Xue YC,Zhou Y,Wu TB,et al.Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping.Molecular Cell,2009,36:996-1006.
  • 2Black DL.Mechanisms of alternative pre-messenger RNA splicing.Annu Rev Biochem,2003,72:291-336.
  • 3Clower CV,Chatterjee D,Wang Z,et al.The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism.Proc Natl Acad Sci USA,2010,107:1894-1899.
  • 4Christofk HR,Vander Heiden MG,Harris MH,et al.The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.Nature,2008,452:230-233.
  • 5Ugurel S,Bell N,Sucker A,et al.Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma.Int J Cancer,2005,117:825-830.
  • 6DI CRISTOFANO A, PESCE B, CORDON-CARDO C, et al. Pten is essential for embryonic development and tumour sup- pression[J]. Nat Genet, 1998, 19(4):348-355.
  • 7LI J, YEN C, LIAW D, et al. PTEN, a putative protein tyro- sine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997, 275(5308):1943-1947.
  • 8NESHAT MS, MELLINGHOFF IK, TRAN C, et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR [J]. PNAS, 2001, 98(18):10314-10319.
  • 9LEE JS, CHOI YD, LEE JH, et al. Expression of PTEN in the progression of cervical neoplasia and its relation to tumor be- havior and angiogenesis in invasive squamous cell carcinoma [J]. J Surg Oncol, 2006, 93(3),233-240.
  • 10CARNERL A, BLANOCO-APARICIO C, RENNER O, et al. The PTEN/PI3K/AKT signalling pathway in cancer, therapeu- tic implications[J]. Curt Cancer Drug Targets, 2008, 8 (3) : 187-198.

共引文献14

同被引文献40

  • 1GHARRAS H E L. Betalain: a particular class of antioxidant pigment [ J ]. Nat Prod Commun, 2011, 6 ( 10 ) : 1425-1431.
  • 2ZHANG C H, LOU R S, OU R, et al. Clinical efficacy of red beet[J]. 中国甜菜糖业,2007.1:45-46,56.
  • 3DING S X. Use red beet to cure cancer[J]. 上海中医药杂志,1960,6(5):238.
  • 4ZHANG Q, PAN J, WANG Y, et al. Beetroot red (betanin) in- hibits vinyl carbamate-and benzo(a) pyrene-induced lung tumori- genesis through apoptosis [ J ]. Mol Carcinog, 2013, 52 ( 9 ) : 686-691.
  • 5DANIEL L, WREGE K, STONER G, et al. Bock redbeetroot dye inhibits proliferation in squamous cell carcinoma of the head and neck[J]. Cancer Res, 2013, 73(8 suppl) : 2267A.
  • 6KAPADIA G J, AAZUINE M A, RAO G S, et al. Cytotoxic effect of the red beetroot (Beta vulgaris L. ) extract compared to doxorubicin ( adriamycin ) in the human prostate ( PC-3 ) and breast ( MCF-7 ) cancer cell lines [ J ]. Anticancer Agents Med, 2011, 11(3) :280-254.
  • 7LECHNER J F, WANG L S, ROCHA C M, et al. Drinking wa- ter with red beetroot food color antagonizes esophageal carcino- genesison NMBA-treated rats[J]. J Med Food, 2010, 13(3) : 733-739.
  • 8LANGMEAD B, SALZBERG S L. Fast gapped-read alignment with Bowtie 2[J]. Nat Methods, 2012, 9(4):357-359.
  • 9PARKIN K L M. Wettasinghe. Cancer Chemoprevenfive Agents [P]. US Patent 2003/0036565 A1, 2003.
  • 10KAPADIA G J, AZUINE M A, SRIDHAR R, et al. Chemopre- vention of DMBA-induced UV-B promoted, NOR-l-lnduced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot [ J ]. Phar- rnacol Res, 2003, 47(2) : 141-148.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部